Antibody Lab GmbH

What Antibody Lab GmbH does

Antibody Lab GmbH (also doing business as The Antibody Lab) is a private Vienna-based biotechnology company founded in 2014 with 1–10 employees, that develops immunoassays, preclinical biologics, and mammalian cell lines for life-science partners and customers. Its core technology is the BESTcell™ BAC-based Expression System, which integrates large (~200 kb) chromosomal loci carrying full gene-regulatory environments into CHO or HEK host cells and is reported to deliver up to 100 pcd productivity and roughly 10-fold higher specific productivity than conventional mammalian expression systems for difficult-to-express proteins and complex glycoproteins. The company monetizes through fee-based contract services (cell line development, antibody production, immunoassay and preclinical biologics development), co-development partnerships, out-licensing of biomarker IP (notably NT-proCNP and recombinant Secretory Component), and Austrian/European public grants (FFG, Wirtschaftsagentur Wien, aws, EISMEA). It has served life-science companies, academic/research institutions, and veterinary diagnostics developers through partnerships with Angothera, Otago Innovation, VDxI, Conidia Bioscience, and Biomedica, and operated a dedicated lab at Vienna Biocenter VBC3 from January 2018. In March 2020 the company terminated its license for BAC-based cell line development, a material narrowing of the proprietary platform that anchors its service offering; no subsequent product launches, funding rounds, or operating updates have been disclosed in the available data.

Name

Antibody Lab GmbH

Legal name

The Antibody Lab GmbH

Website

https://theantibodylab.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Antibody Lab GmbH is a Vienna-based private biotech (founded 2014) that develops immunoassays, preclinical biologics, and mammalian cell lines via its proprietary BESTcell™ BAC-based expression system for life-science partners.

Ownership category

akta.pro rank

Product category

Biotechnology Contract Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834)

akta.pro primary industry

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)

Keywords

• Antibody engineering services
• Mammalian cell line development
• Immunoassay development services
• Preclinical biologics development
• Protein expression services

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain

Revenue model

1. Fee-based Services: Contract research services for antibody production and cell line development offered to customers and partners on a fee basis.
2. Co-development Partnerships: Joint development arrangements with partners for specific projects, sharing costs and outcomes.
3. Product Out-licensing: Licensing of proprietary products and biomarkers to partners for commercial exploitation.
4. Public Grants: R&D projects supported by grants from Austrian agencies (FFG, Wirtschaftsagentur Wien, aws) and European public agencies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Antibody Lab GmbH develops immunoassays and preclinical biologics on behalf of its partners and customers by leveraging proprietary antibody engineering and protein expression know-how. The company's foundation is the BESTcell™ BAC-based mammalian cell expression system for developing stable, high-producing cell lines in CHO or HEK cells. Its offerings include cell line development, antibody production, immunoassay development, and preclinical biologics development, delivered as fee-based contract research, co-development partnerships, and out-licensing arrangements.

Product overview

The Antibody Lab GmbH is a private biotechnology company offering a portfolio of antibody engineering and protein expression services. Its core proprietary technology is the BESTcell™ Mammalian Cell Expression System, a BAC-based expression system for developing stable, high-producing cell lines. The company provides complementary services including Cell Line Development (non-GMP), Antibody Production Service, Immunoassays Development, and Preclinical Biologics Development. These offerings leverage the BESTcell™ platform technology and the company's specialized expertise in mammalian cell expression to deliver high-titer production of complex glycoproteins and monoclonal antibodies for research and bioproduction applications.

Differentiator

Problem solved

Functional benefit

Brands

• BESTcell™: BAC-based Expression System Technology in mammalian cells for stable, high-producing cell line development and protein expression.

Products and services

• BESTcell™ Mammalian Cell Expression System A BAC-based Expression System Technology (BESTcell™) for developing stable, high-producing mammalian cell lines in CHO or HEK cells, using BAC vectors that integrate full loci of mammalian transcription hotspots with chromatin and gene regulatory elements. Designed for customers needing extremely high product yield and titer (up to 100 pcd) for complex glycoproteins and monoclonal antibodies, with demonstrated ~10-fold higher specific productivity than conventional systems for difficult-to-express proteins.
• Cell Line Development Service

Quantifiable outcome

• Up to 100 pcd productivity achieved with BESTcell™ system
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered core and minor.

• AngotheracoreStrategic or Co-development Partner · 14 April 2017Collaboration on development of Animal Health vaccines.
• Veterinary Diagnostics Institute (VDxI)coreChannel Partner/ Reseller/ Distributor · 3 August 2016Agreement for further development of proprietary point-of-care assay to diagnose sepsis in companion animals. VDxI responsible for clinical development and marketing in North America.
• Conidia BioscienceminorStrategic or Co-development Partner · 12 February 2016Undertaking feasibility and assay development work on Conidia's specific proprietary antigens for fuel tests detecting microbiological contamination.
• BiomedicaminorOEM/ Whitelabel/ Licensing Partner · 6 November 2015Acquired rights for diagnosis of septic complications based on NT-proCNP in human and veterinary medicine from Biomedica.
• Otago Innovation Ltd.coreOEM/ Whitelabel/ Licensing Partner · 21 October 2015Worldwide exclusive license agreement on diagnostic use of NT-proCNP biomarker for improving screening for women at risk of adverse events later in pregnancy.
• Angothera GmbHcoreOEM/ Whitelabel/ Licensing Partner · 1 September 2015License agreement for use and commercial exploitation of Angothera's IP-Rights on recombinant Secretory Component. Also collaborated on Animal Health vaccines development in 2017.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Market position

Strengths5 records

Weaknesses3 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/the-antibody-lab

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Antibody Lab GmbH